Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today provided additional details on ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...

These widespread problems are reflected in the fact that race is one of the most entrenched and polarizing topics in U.S. medical education ... based diagnostic bias Presentation of links between ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Each poses specific barriers to quality medical care and good health and ... most hesitant to get a COVID-19 vaccine He cited several examples from numerous studies he’s written, including ...

Data contribute to growing body of support around the anti-fibrotic activity of EFX in patients with pre-cirrhotic MASH SOUTH SAN FRANCISCO, Calif., May (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc.

All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday in the last week of the fall and winter semesters ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only ...

We are delighted to have been awarded a £9 million Wellcome grant to develop a new Discovery Research Platform for Medical Humanities (DRP-MH). The Platform will create space for experimentation and ...

Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...